Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-11-022483
Filing Date
2011-04-11
Accepted
2011-04-11 16:13:57
Documents
2
Period of Report
2011-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1517
2 POA DOCUMENT poa.txt EX-24.3_373508 3418
  Complete submission text file 0001209191-11-022483.txt   6391
Mailing Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130 8585520866
ADVENTRX PHARMACEUTICALS INC (Issuer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 421 BRIDOON TERRACE ENCINITAS CA 92024
Business Address
Shuster Lewis (Reporting) CIK: 0001471131 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32157 | Film No.: 11752815